Dr. Melissa Krystel-Whittemore, MD
What this data tells you about Dr. Krystel-Whittemore
Dr. Melissa Krystel-Whittemore is a pathology - anatomic specialist in Boston, MA, with 10 years of NPI registration. Based on federal Medicare data, Dr. Krystel-Whittemore performed 897 Medicare services across 528 unique beneficiaries.
Between the years covered by Open Payments, Dr. Krystel-Whittemore received a total of $8,342 from 2 pharmaceutical and/or device companies across 3 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pathology - anatomic. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Krystel-Whittemore is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Moderately high complexity pathology tissue examination A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This specific level of complexity involves a moderate to high degree of technical skill and interpretation. |
207 | $71 | $575 |
| Tissue pathology examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue. |
143 | $65 | $425 |
| Molecular pathology test interpretation A physician reviews and interprets the results of a molecular pathology test to provide a diagnostic report. |
120 | $40 | $108 |
| Manual microscopic genetic analysis of tumor A laboratory test that uses a microscope to manually examine tumor tissue for genetic changes. |
118 | $108 | $894 |
| Tissue staining for diagnosis, additional An extra laboratory procedure to apply special stains to tissue slides for detailed examination. |
93 | $79 | $375 |
| Tissue staining for diagnosis, initial A laboratory test where special stains are applied to tissue slides to help examine the cells and identify specific characteristics. |
61 | $92 | $445 |
| Pathology tissue examination and preparation A pathologist examines, dissects, and prepares tissue samples for analysis. |
49 | $23 | $225 |
| Intraoperative pathology examination, first tissue block A pathologist examines a tissue sample removed during surgery to provide a preliminary diagnosis. This test is performed on the first tissue block obtained from the procedure. |
31 | $53 | $435 |
| Limited pathology tissue examination A microscopic examination of tissue samples to identify abnormalities. This limited exam focuses on specific aspects of the tissue rather than a comprehensive analysis. |
25 | $4 | $55 |
| X-ray of surgical specimen | 22 | $13 | $80 |
| Computer-assisted genetic tissue analysis A microscopic genetic analysis of tissue using computer-assisted technology for the initial multiplex procedure. |
14 | $36 | $302 |
| Additional manual multiplex genetic stain A microscopic genetic analysis performed manually using an additional multiplex stain procedure on tissue. |
14 | $54 | $438 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
All-time payments by company (2022-2024) ›
Associated products mentioned in payments ›
The majority of payments (99%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 9% for pathology - anatomic in MA.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Krystel-Whittemore is a mixed practice specialist, with moderate Medicare volume, with consulting-driven industry engagement in the top 9% of MA peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Krystel-Whittemore experienced with moderately high complexity pathology tissue examination?
Does Dr. Krystel-Whittemore receive payments from pharmaceutical companies?
How do Dr. Krystel-Whittemore's costs compare to other pathology - anatomics in Boston?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology